List of SBIR/STTR awards granted to GLSynthesis Inc.

where

SBIR/STTR Award Recipient

GLSynthesis Inc.

Name	Description	SBIR/STTR Award Recipient	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ GLSynthesis Inc. SBIR Phase II Award, July 2013	A SBIR Phase II contract was awarded to GLSynthesis Inc. in July, 2013 for $3,396,941.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	9R44TR000983-04A1	Phase II	3,396,941	July 5, 2013	sbir.gov/node/1032151
‌ GLSynthesis Inc. SBIR Phase I Award, January 2015	A SBIR Phase I contract was awarded to GLSynthesis Inc. in January, 2015 for $243,266.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43GM110858-01A1	Phase I	243,266	January 1, 2015	sbir.gov/node/1044967
‌ GLSynthesis Inc. STTR Phase I Award, January 2015	A STTR Phase I contract was awarded to GLSynthesis Inc. in January, 2015 for $320,466.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	STTR	1R41GM110813-01A1	Phase I	320,466	January 15, 2015	sbir.gov/node/1028387
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $1,548,120.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44HL088828-02	Phase II	1,548,120		sbir.gov/content/novel-antithrombotic-diadenosine-tetraphosphate-analogs-2
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44AR046396-02A1	Phase I	0		sbir.gov/content/new-dermal-anesthetics-2
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $307,138.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43AI051103-01A1	Phase I	307,138		sbir.gov/content/dna-polymerase-iiie-new-antibiotic-target-0
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $3,000,000.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44AI051103-04	Phase II	3,000,000		sbir.gov/content/preclinical-development-novel-antibacterial-clostridium-difficile-diseas
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44GM060828-02	Phase I	0		sbir.gov/content/hybrid-molecules-designed-enhance-antibiotic-activity-0
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $253,746.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43AI055128-01	Phase I	253,746		sbir.gov/content/antiviral-drugs-treatment-herpes-b-infections-0
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $262,854.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43RR016401-01A1	Phase I	262,854		sbir.gov/content/fluorosome-technique-drug-permeability-studies-0
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $299,848.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43AI091287-01	Phase I	299,848		sbir.gov/node/4927
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $299,670.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43HL081992-01A1	Phase I	299,670		sbir.gov/content/diadenosine-boranotetraphosphonates-antithrombotic-drugs-0
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $3,396,941.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	9R44TR000983-04A1	Phase II	3,396,941		sbir.gov/node/678950
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $191,458.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43GM093694-01	Phase I	191,458		sbir.gov/node/1070679
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $1,851,180.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44AI051103-02A1	Phase II	1,851,180		sbir.gov/content/dna-polymerase-iiie-new-antibiotic-target-2
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $1,078,180.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44GM075397-02	Phase II	1,078,180		sbir.gov/content/rapid-vitro-substrate-assay-multi-drug-resistance-p-glycoprotein-0
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $333,166.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43HL088828-01	Phase I	333,166		sbir.gov/content/novel-antithrombotic-diadenosine-tetraphosphate-analogs-0
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $933,529.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44RR016401-02A1	Phase II	933,529		sbir.gov/content/fluorosome-technique-drug-permeability-studies-2
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $363,564.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43GM109505-01	Phase I	363,564		sbir.gov/node/705867
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $2,464,310.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44GM070035-02	Phase II	2,464,310		sbir.gov/content/non-sedating-atropisomeric-drugs-atopic-diseases-0
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $255,352.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43GM073279-01A1	Phase I	255,352		sbir.gov/content/high-throughput-membrane-water-partition-coefficients-0
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $140,384.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43GM075397-01	Phase I	140,384		sbir.gov/content/vitro-substrate-assay-multi-drug-resistance-0
‌ GLSynthesis Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to GLSynthesis Inc. for $237,357.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	1R43AR063503-01A1	Phase I	237,357		sbir.gov/node/677542
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $1,688,750.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44AG015259-04	Phase II	1,688,750		sbir.gov/node/1070379
‌ GLSynthesis Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to GLSynthesis Inc. for $1,927,195.0 USD from the U.S. Department of Health & Human Services.	GLSynthesis Inc.	SBIR	2R44AR046396-02A1	Phase II	1,927,195		sbir.gov/content/new-dermal-anesthetics-4

Results per page:

33 results

0 selected

33 results

0 selected